Baduanjin review suggests functional benefits in chronic heart failure, with reporting gaps
Pooled trials favored Baduanjin for quality of life and exercise capacity, but unclear outcome reporting limits interpretation of the size and durability of benefits.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
The review reported favorable quality-of-life, exercise-capacity and psychological outcomes with Baduanjin in people with chronic heart failure. However, the abstract does not name the measurement scales, and a nonsignificant result is not clearly tied to an outcome. The findings are suggestive, but they do not establish how large or durable a patient-relevant benefit would be.
The abstract leaves longer follow-up periods and comparison treatments unspecified. It also reports a nonsignificant risk ratio without clearly naming its outcome, preventing a reliable interpretation of that result.
Longer practice needs clearer comparisons
The authors describe more pronounced improvements with longer practice than with short-term exercise. Without clearly reported follow-up periods and details of that comparison, the abstract does not establish a specific duration that produces better results.
Safety reporting has limits
The safety analysis reported no serious adverse events. This is a description of the available reports, rather than proof that harms cannot occur; the abstract does not explain how safety was monitored.
The original publication
Effects of Long-Term Baduanjin Exercise on the Effectiveness and Safety of Cardiac Rehabilitation in Patients with Chronic Heart Failure: A Systematic Review and Meta-Analysis.
Sun X, Ping W, Ma L
J Integr Complement Med · 2026
- PubMed ID
- 41313613
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.